Related Experiment Videos
Anaesthesia for a child with centronuclear myopathy
Insights
Centronuclear myopathy (CNM) is a rare inherited muscle disorder. This case study shows a seven-year-old male with CNM underwent successful surgery using propofol anesthesia, with no signs of malignant hyperpyrexia.
Area of Science:
- Neurology
- Anesthesiology
- Genetics
Background:
- Centronuclear myopathy (CNM) is a rare inherited neuromuscular disorder affecting muscle fibers.
- Historically, CNM has not been linked to an increased risk of malignant hyperpyrexia (MH).
- This case explores anesthesia management in a pediatric patient with CNM.
Observation:
- A seven-year-old male diagnosed with CNM was scheduled for elective surgery.
- The patient received high-dose propofol anesthesia, combined with nitrous oxide (N2O) and oxygen (O2).
- Anesthesia was administered using a new anesthesia machine.
Findings:
- The surgical procedure was completed successfully.
- The patient experienced uncomplicated anesthesia and recovery post-operation.
- No adverse events, including malignant hyperpyrexia, were observed during or after anesthesia.
Implications:
- This case suggests that propofol anesthesia may be safely used in pediatric patients with CNM.
- It challenges the previous assumption of an unassociated risk of malignant hyperpyrexia in CNM patients.
- Further research is warranted to confirm the safety profile of propofol in CNM patients undergoing surgery.
Abstract:
Centronuclear myopathy (CNM) is an inherited condition involving most muscle fibres in all the body mass, first described in 1966, which has a varying spectrum of presentations. Until recently it had not been associated with an increased risk of malignant hyperpyrexia. A seven-year-old male with CNM was admitted to our hospital for elective surgery. High dose propofol anaesthesia was used, supplemented with N2O/O2 from a new anaesthesia machine. The operation was successful with uncomplicated anaesthesia and recovery.